Arrowstreet Capital
MGNX icon

Arrowstreet Capital’s MacroGenics MGNX Stock Holding History

Arrowstreet Capital’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-156,493
Closed -$1.5M – 1720
2023
Q4 		$1.5M Buy
+156,493
New +$1.08M ﹤0.01% 1022
2021
Q2 		– Sell
-124,156
Closed -$3.95M – 2090
2021
Q1 		$3.95M Sell
124,156
-145,172
-54% -$3.53M 0.01% 1280
2020
Q4 		$6.16M Buy
269,328
+88,670
+49% +$2.04M 0.01% 1111
2020
Q3 		$4.55M Sell
180,658
-217,680
-55% -$5.94M 0.01% 1180
2020
Q2 		$11.1M Buy
398,338
+347,538
+684% +$6.04M 0.02% 736
2020
Q1 		$296K Buy
+50,800
New +$461K ﹤0.01% 1650
2019
Q2 		– Sell
-143,385
Closed -$2.58M – 1575
2019
Q1 		$2.58M Buy
143,385
+4,695
+3% +$81.2K 0.01% 1024
2018
Q4 		$1.76M Buy
138,690
+115,027
+486% +$1.93M ﹤0.01% 827
2018
Q3 		$507K Buy
+23,663
New +$504K ﹤0.01% 898
2017
Q2 		– Sell
-24,528
Closed -$456K – 1224
2017
Q1 		$456K Buy
+24,528
New +$473K ﹤0.01% 1107
2016
Q4 		– Sell
-94,468
Closed -$2.83M – 2196
2016
Q3 		$2.83M Buy
+94,468
New +$2.81M 0.01% 829

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Arrowstreet Capital's MGNX Position: Q1 2024 in Review

Arrowstreet Capital sold out of MacroGenics (MGNX) in Q1 2024, closing a stake of 156,493 shares — an estimated $1.5M sold.

Arrowstreet Capital first reported a position in MGNX in Q3 2016 and held it in 11 quarters. The position peaked at $11.1M in Q2 2020. 163 funds tracked by Wall St. Rank hold MGNX as of Q1 2024.

  • Arrowstreet Capital reported no remaining MacroGenics position as of Q1 2024 after selling out during the quarter.
  • Arrowstreet Capital sold 156,493 MacroGenics shares in Q1 2024, an estimated $1.5M.
  • Arrowstreet Capital first reported a position in MacroGenics in Q3 2016 and held it in 11 quarters.
  • Arrowstreet Capital's MacroGenics position peaked at $11.1M in Q2 2020.
  • 163 funds tracked by Wall St. Rank held MacroGenics as of Q1 2024.

Based on Arrowstreet Capital's 13F filing for Q1 2024, filed 15 May 2024.